Skip to content

Effect of Nutritional Management on RIOM in Patients With Advanced Head and Neck Cancer

A Prospective Single-arm Cohort Study on the Effect of Peri-radiotherapy Nutrition Management on Radiation-induced Oral Mucositis in Patients With Advanced Head and Neck Cancer

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05721885
Enrollment
60
Registered
2023-02-10
Start date
2023-03-01
Completion date
2025-12-31
Last updated
2023-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer, Nutrition Related Cancer, Radiation-Induced Mucositis

Keywords

Head and Neck Cancer, Malnutrition, Radiation-induced Oral Mucositis, nutrition management

Brief summary

The goal of this clinical trial is to learn about the effect of nutritional management on radiation-induced oral mucositis in patients with advanced head and neck cancer during the peri-radiotherapy period . The main questions it aims to answer are: * \[question 1\]Whether whole-course nutritional intervention can improve radiation-induced oral mucositis in patients with HNC. * \[question 2\]Whether whole-course nutritional intervention can improve nutritional status and inflammation. Participants will be treated according to the NCCN guidelines. In addition, clinical pharmacists and registered dietitians provided nutritional intervention strategies based on clinical and nutritional assessments for the patients in the peri-radiotherapy nutrition group. Researchers will compare clinical routine examination and nutritional indicators between the standard treatment group and the peri-radiotherapy nutrition management group to see if nutrition management effects.

Interventions

Nutritional management was performed by clinical pharmacists and registered dietitians to develop nutritional intervention strategies based on patient clinical assessment and nutritional assessment. PG-SGA score was 0-3 points, and diet guidance was given. PG-SGA score \> 4 points, artificial nutrition intervention was carried out, and the way and amount of nutritional intervention were clarified to achieve the final daily energy and protein target requirements. Nutritional interventions and assessments were adjusted over time.

Sponsors

Jing Yan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Group A: standard treatment group, standard anti-tumor treatment, clinicians in accordance with the NCCN anti-tumor treatment guidelines. Group B: peri-radiotherapy nutrition management group, standard anti-tumor therapy combined with peri-radiotherapy nutrition management.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Aged between 18 and 80 years old * Advanced head and neck cancer (III-IV inoperable) is clearly diagnosed * Predicted survival time \> 3 months * Radical radiotherapy combined with chemotherapy or immunotherapy was performed in our hospital * The patient has clear consciousness and no communication disorder * Informed consent and voluntary participation in this study

Exclusion criteria

* Patients with previous surgery or radiotherapy for head and neck cancer * Patients with concurrent or previous history of other tumors * Distant metastasis * Patients with allergy, intolerance or contraindication to enteral nutrition or parenteral nutrition * Severe renal insufficiency (eGFR\<30ml/min/1.73m2) * Combined with poorly controlled metabolic diseases such as diabetes * Doctors or researchers deem that they are not suitable to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Degree of radiation-induced oral mucositis (RTOG criteria)six monthsThe Radiation Oncology Group (RTOG) grade of acute radiation injury was used for evaluation, which was divided into 0 to Ⅳ grades. The mild grade included 0, Ⅰ, and Ⅱgrades (grade 0 was no mucosal response; GradeⅠ: erythema, mild pain; GradeⅡ: spotty mucositis with serous exudation), severe grade Ⅲ- IV (Ⅲ: patchy fibrous mucositis with severe pain; Grade IV: necrosis, ulcer, hemorrhage).

Contacts

Primary ContactWang Shu An, bachelor
glyywsa@163.com18801599435

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026